PQQ Review: Human Cognitive Trials and Mitochondrial Claims

Page Contents

PQQ Review: Human Cognitive Trials and Mitochondrial Claims

Pyrroloquinoline quinone (PQQ) is studied for cellular and mitochondrial effects and is sold in supplements with brain-health claims. Small human cognitive trials exist, but they do not establish that PQQ extends human life, creates new brain power plants in supplement users or reliably improves everyday mental energy.

Why mitochondria appear in PQQ marketing

Mitochondria participate in energy production, and laboratory work has examined PQQ-related redox signalling and mitochondrial biology. The older article made this useful biological topic harder to assess by mixing it with stardust stories and broad anti-aging promises. Origin stories are not evidence of a health benefit.

A change in a cellular pathway is not the same as improved memory, and an animal learning result is not a human clinical result. PQQ should not be called an established essential human vitamin or a correction for an assumed deficiency on the basis of that work.

Not this kind of Stardust. — By Rik Walton [CC BY-SA 2.0], via Wikimedia Commons

What the cognitive studies show

A 12-week randomized placebo-controlled study in 41 older healthy participants used 20 mg daily of a defined PQQ preparation. It reported an improvement on a selected attention measure. A separate small trial evaluated a different defined PQQ preparation and reported changes in several cognitive scores. These are reasons for further study, not proof that every PQQ product works.

A 2023 placebo-controlled study also examined 20 mg daily and reported memory findings, with analyses by age. Small samples, multiple endpoints, age subgroups and ingredient-industry involvement deserve consideration when judging how robust and independently reproducible the findings are. Positive test scores do not establish dementia prevention.

From the Hubble telescope: Image of galaxy NGC 1672. Shown are star-forming clouds and dark bands of interstellar dust, which may or may not be loaded with PQQ. By NASA, ESA, and The Hubble Heritage Team (STScI/AURA)-ESA/Hubble Collaboration [Public domain], via Wikimedia Commons — By NASA, ESA, and The Hubble Heritage Team (STScI/AURA)-ESA/Hubble Collaboration [Public domain], via Wikimedia Commons

Do not attribute a combination result to PQQ alone

The archive discussed PQQ paired with CoQ10 and an uncontrolled fatigue/sleep experiment. A combination cannot isolate PQQ, and an uncontrolled before-and-after study cannot rule out expectation, natural fluctuation or other changes. These limitations apply even when participants report feeling better.

The proposed benefit of a mitochondrial stack containing PQQ, CoQ10 and carnitine has to be tested as that specific combination. Plausible complementary mechanisms are not evidence of clinical synergy.

Mitochondria image By NIH (NIH) [Public domain], via Wikimedia Commons — By NIH (NIH) [Public domain], via Wikimedia Commons

Practical interpretation

The 20 mg amount is frequently encountered in research, but a study amount is not an established optimal cognitive dose. Short studies with few participants cannot exclude uncommon adverse effects or settle long-term safety, medication interactions, pregnancy or breastfeeding use. The earlier inference that a naturally occurring molecule must be safe has been removed.

For label comparison, identify the exact PQQ form, amount and other active ingredients. A branded ingredient can help identify what was studied but is not itself proof of superiority. PQQ is a preliminary cognitive-research ingredient with interesting biology; the current evidence does not justify a promise of cognitive longevity or a blanket recommendation to buy a mitochondrial blend.